IPO11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.619200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.497200E-01
Normal-vs-Stage2
6.443600E-01
Normal-vs-Stage3
4.812800E-01
Normal-vs-Stage4
8.218200E-01
Stage1-vs-Stage2
3.336800E-01
Stage1-vs-Stage3
2.341000E-01
Stage1-vs-Stage4
9.784400E-01
Stage2-vs-Stage3
5.759400E-01
Stage2-vs-Stage4
4.427000E-01
Stage3-vs-Stage4
3.556800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.651400E-01
Normal-vs-AfricanAmerican
8.069200E-01
Normal-vs-Asian
2.562800E-01
Caucasian-vs-AfricanAmerican
8.474200E-01
Caucasian-vs-Asian
1.432630E-01
AfricanAmerican-vs-Asian
3.060800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.689800E-01
Normal-vs-Female
8.029800E-01
Male-vs-Female
1.953780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.227200E-01
Normal-vs-Age(41-60Yrs)
9.383200E-01
Normal-vs-Age(61-80Yrs)
4.519800E-01
Normal-vs-Age(81-100Yrs)
8.275000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.832000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.016200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.419800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.802900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.529800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.900100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.427200E-01
Normal-vs-Daily Drinker
4.692200E-01
Normal-vs-Weekly Drinker
3.961200E-01
Normal-vs-Occasional Drinker
8.759000E-01
Normal-vs-Social Drinker
7.564000E-01
Non Drinker-vs-Daily Drinker
9.513400E-01
Non Drinker-vs-Weekly Drinker
7.706600E-01
Non Drinker-vs-Occasional Drinker
2.431400E-01
Non Drinker-vs-Social Drinker
5.307600E-01
Daily Drinker-vs-Weekly Drinker
7.460800E-01
Daily Drinker-vs-Occasional Drinker
2.985400E-01
Daily Drinker-vs-Social Drinker
5.916600E-01
Weekly Drinker-vs-Occasional Drinker
2.303200E-01
Weekly Drinker-vs-Social Drinker
4.715200E-01
Occasional Drinker-vs-Social Drinker
7.291600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.699200E-01
Normal-vs-Grade 2
7.949200E-01
Normal-vs-Grade 3
8.444000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.018800E-01
Grade 1-vs-Grade 3
7.287200E-01
Grade 1-vs-Grade 4
8.699200E-01
Grade 2-vs-Grade 3
3.867000E-01
Grade 2-vs-Grade 4
7.949200E-01
Grade 3-vs-Grade 4
8.444000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.943600E-01
Normal-vs-NonDiabetic
5.512000E-01
Diabetic-vs-NonDiabetic
8.292600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.066600E-01
Normal-vs-NoPancreatitis
6.106000E-01
Pancreatitis-vs-NoPancreatitis
2.490800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.820200E-01
Normal-vs-N1
7.065200E-01
N0-vs-N1
6.734000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.595000E-01
Normal-vs-TP53-NonMutant
9.067600E-01
TP53-Mutant-vs-TP53-NonMutant
2.038400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
